High-Throughput Echocardiography-Guided Induction of Myocardial Ischemia/Reperfusion in Mice.

Background

Mouse models of myocardial ischemia with subsequent heart failure are common approaches to examine heart failure pathology and possible treatment strategies. We sought to establish a high-throughput approach for echocardiography-guided induction of myocardial ischemia/reperfusion (IR) in mice.

Methods

After visualization of the left coronary artery with high-resolution ultrasound imaging and echocardiographic definition of the level of coronary occlusion, the left anterior descending artery was temporarily occluded with 2 micromanipulator-controlled needles. Functional and molecular changes were assessed and compared with commonly performed surgical techniques.

Results

Echocardiography-guided induction of myocardial IR enabled standardized induction of myocardial IR injury with subsequent left ventricular remodeling. Incorporation of various quality control measures throughout the procedure ensured a high success rate and the absence of relevant postinterventional mortality in experienced hands. Compared with surgical approaches, echocardiography-guided induction of myocardial IR showed a quicker recovery time and induced a less pronounced inflammatory response characterized by decreased local and systemic neutrophil counts. Notably, infarct size and subsequent post-myocardial infarction cardiac dysfunction were comparable between methods. The novel procedure was successfully implemented at different academic institutions with imaging expertise and demonstrated high interinstitutional reproducibility.

Conclusions

Echocardiography-guided induction of myocardial IR enables high-throughput induction of myocardial IR injury with precise echocardiographic definition of the occlusion level and immediate evaluation of cardiac function during ischemia. The method provides a more clinically relevant assessment of IR sequelae and offers notable animal welfare advantages by eliminating the need for ventilation and thoracotomy, thereby mitigating potential surgery-related confounders.

CommentIn

Circ Res. 2025 May 9;136(10):1110-1112. doi: 10.1161/CIRCRESAHA.125.326461.

COI Statement

F. Sicklinger, T.C. Kuhn, and F. Leuschner are scientific cofounders of HEICor BMI GmbH, Germany, which filed a provisional patent application for the platform/manipulator system (24185 082.5). The other authors report no conflicts.

References:

• Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, et al. ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149:e347–e913. doi: 10.1161/CIR.0000000000001209
• Hilgendorf I, Frantz S, Frangogiannis NG. Repair of the infarcted heart: cellular effectors, molecular mechanisms and therapeutic opportunities. Circ Res. 2024;134:1718–1751. doi: 10.1161/CIRCRESAHA.124.323658
• Lindsey ML, Brunt KR, Kirk JA, Kleinbongard P, Calvert JW, de Castro Brás LE, DeLeon-Pennell KY, Del Re DP, Frangogiannis NG, Frantz S, et al. . Guidelines for in vivo mouse models of myocardial infarction. Am J Physiol Heart Circ Physiol. 2021;321:H1056–H1073. doi: 10.1152/ajpheart.00459.2021
• Sicklinger F, Zhang Y, Lavine KJ, Simon N, Bucher V, Jugold M, Lehmann L, Konstandin MH, Katus HA, Leuschner F. A minimal-invasive approach for standardized induction of myocardial infarction in mice. Circ Res. 2020;127:1214–1216. doi: 10.1161/CIRCRESAHA.120.317794
• Lindsey ML, Bolli R, Canty JM, Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, et al. . Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. 2018;314:H812–H838. doi: 10.1152/ajpheart.00335.2017